Vertex Pharmaceuticals
VRTX
#137
Rank
A$191.05 B
Marketcap
$741.86
Share price
0.25%
Change (1 day)
22.81%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2024 (TTM): A$0.40 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$10.62 Billion. In 2023 the company made an earning of A$6.99 Billion, an increase over its 2022 earnings that were of A$6.77 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.40 B-94.18%
2023 A$6.99 B3.19%
2022 A$6.77 B53.56%
2021 A$4.41 B-12.06%
2020 A$5.01 B118.45%
2019 A$2.29 B120.64%
2018 A$1.04 B1473.64%
2017 A$66.18 M197.6%
2016 A$22.23 M-102.97%
2015 -A$0.75 Billion-28.46%
2014 -A$1.05 Billion-51.5%
2013 -A$2.16 Billion-30584.68%
2012 A$7.07 M-95.47%
2011 A$0.15 B
2009 -A$0.94 Billion
2007 -A$0.66 Billion83.1%
2006 -A$0.36 Billion59.02%
2005 -A$0.23 Billion3.28%
2004 -A$0.22 Billion-38.16%
2003 -A$0.36 Billion
2000 -A$60.15 Million-20.38%
1999 -A$75.54 Million31.62%
1998 -A$57.39 Million91.05%
1997 -A$30.04 Million-36.24%
1996 -A$47.12 Million12.45%
1995 -A$41.9 Million27.4%
1994 -A$32.89 Million-1833.33%
1993 A$1.89 M-112.12%
1992 -A$15.66 Million175%
1991 -A$5.7 Million-12.2%
1990 -A$6.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$0.27 B-40.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.37 B 2,315.10%๐Ÿ‡บ๐Ÿ‡ธ USA
A$23.67 B 4,924.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.88 Billion-2,408.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.08 B 6,072.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.17 Billion-135.86%๐Ÿ‡บ๐Ÿ‡ธ USA